Welsh firm Antiverse raises funds for AI antibody platform Cardiff's Antiverse has raised $9.3m to develop its AI-based design platform for antibodies against hard-to-reach targets like GPCRs and ion channels.

#UKbiotech #Antiverse has raised $9.3 million to accelerate its #drugdiscovery programmes, based on an #AI-powered platform for designing #antibodybasedtherapeutics.

pharmaphorum.com/news/welsh-f...

Scancell points to 'strong' melanoma vaccine data Scancell has the results it was hoping for with its melanoma immunotherapy iSCIB1+ and is accelerating plans for a pivotal trial.

#Scancell #NationalCancerInstitute #UKbiotech #DNAplasmidvaccine #melanoma #SCOPEtrial #SCIB1 #iSCIB1+ #checkpointinhibitortherapy #advancedmelanoma #immunotherapy #melanomaantigens #TRP2protein #Tcells #checkpointinhibitors #metastaticmelanomatreatment
pharmaphorum.com/news/scancel...

UK Custom Antibody Market Size, Growth Report 2035 UK Custom Antibody Market Industry is expected to grow from 7.5(USD Million) in 2024 to 20.67 (USD Million) by 2035. The UK Custom Antibody Market CAGR (growth rate) is expected to be around 9.657% du...

🔬 UK’s custom antibody market is tailored for success! Advancing diagnostics one cell at a time 🇬🇧🧫
#CustomAntibody #UKBiotech #LifeSciences #DiagnosticsInnovation #MedicalResearch

www.marketresearchfuture.com/reports/uk-c...

We’re excited to share our new report: A Vision for the UK Life Sciences Sector in 2035 ➡️ shorturl.at/XVtet

Too often #UKbiotech innovations stop short of commercial success. A shift in mindset towards scale, ambition, and long-term capital is needed to realise the sector’s full potential.

#UKbiotech has had a strong start to 2025, raising £881 million in venture capital in Q1. ➡️ biotechfinance.org

Landmark financings from companies like Isomorphic Labs and Verdiva Bio demonstrate confidence in UK innovation, especially in AI-driven 💊 #DrugDiscovery and next-gen therapeutics.

🚀 We’re excited to feature Cambridge Innovation Capital and its work in supporting #Innovation in this year’s UK biotech financing report ➡️ t.co/4kxLgR4YAQ

With the Chancellor’s plans to develop Europe’s #SiliconValley between 📍#Oxford and #Cambridge, the future looks bright for 🧬 #UKbiotech.

📝 In this blog, Albert MK, Media and Communications Executive at the @BIA_UK, delves into insights from the BIA’s pre-Gala Dinner event, where industry leaders explored the impact of Trump’s presidency on 🧬 #UKbiotech and the opportunities it presents.

🚀 Have You Read the UK biotech financing report yet? ➡️ biotechfinance.org

Our latest #UKbiotech financing report is packed with inspiring case studies of companies securing funding to drive 🚀 innovation, fuel R&D, and strengthen the UK’s position as a #GlobalBiotech leader 👏

#InvestinBiotech